Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2'-hydroxypropyl)-2-methyl-5- Nitroimidazole
2. 14,539 Rp
3. Minovag
4. Sabima
5. Secnidal
6. Secnol
7. Solosec
1. 3366-95-8
2. Secnidazol
3. Flagentyl
4. Secnidazolum
5. 1-(2-methyl-5-nitro-1h-imidazol-1-yl)propan-2-ol
6. Secnidazolum [inn-latin]
7. Solosec
8. Rp 14539
9. Secnidal
10. 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
11. Pm 185184
12. Pm-185184
13. Sym-1219
14. Secnidazole Anhydrous
15. Rp-14539
16. Secnidazole (flagentyl)
17. Ornidazole Metabolite M4
18. 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol
19. Nsc-759812
20. Mls000559043
21. 1-(2-methyl-5-nitro-imidazol-1-yl)-propan-2-ol
22. R3459k699k
23. Ncgc00095158-01
24. Smr000149359
25. Rp-14539;pm-185184
26. Dsstox_cid_25934
27. Dsstox_rid_81233
28. Dsstox_gsid_45934
29. Secnidazol [inn-spanish]
30. Cas-3366-95-8
31. Sr-01000685111
32. Einecs 222-134-0
33. Alpha,2-dimethyl-5-nitro-1h-imidazole-1-ethanol
34. Sindose
35. Secnil
36. Unii-r3459k699k
37. 1-(2-hydroxypropyl)-2-methyl-5-nitroimidazol
38. Secnidal (tn)
39. Secnidazole-[d6]
40. Secnidazole [usan:inn:ban:dcf]
41. Sym 1219
42. Solosec (tn)
43. Secnidazole [mi]
44. Opera_id_1811
45. Spectrum2_000033
46. Spectrum3_001956
47. Secnidazole [inn]
48. Alpha,2-dimethyl-5-nitroimidazole-1-ethanol
49. Secnidazole (usan/inn)
50. Secnidazole [usan]
51. 1-(2-methyl-5-nitroimidazol-1-yl)-2-propanol
52. Imidazole-1-ethanol, Alpha,2-dimethyl-5-nitro-
53. Secnidazole [mart.]
54. Bspbio_003556
55. Secnidazole [who-dd]
56. Mls000759496
57. Mls001201813
58. Mls001424126
59. Mls006011434
60. Schembl363924
61. Spectrum1505304
62. Spbio_000125
63. 1h-imidazole-1-ethanol, .alpha.,2-dimethyl-5-nitro-
64. Chembl498847
65. Dtxsid3045934
66. Chebi:94433
67. Kbio3_002874
68. Secnidazole [orange Book]
69. Chebi:140628
70. Hms1922b12
71. Hms2051c20
72. Hms2090n15
73. Hms2231g11
74. Hms3369n08
75. Hms3393c20
76. Hms3656g14
77. Hms3714i05
78. Pharmakon1600-01505304
79. Bcp12459
80. Hy-b1118
81. Tox21_111457
82. Bbl010784
83. Bdbm50349330
84. Ccg-39993
85. Mfcd00864656
86. Nsc759812
87. Stk590474
88. Akos005512552
89. Akos025149490
90. Tox21_111457_1
91. Ccg-100896
92. Cs-4641
93. Db12834
94. Ks-1191
95. Nc00146
96. Nsc 759812
97. Sb19197
98. Secnidazole 100 Microg/ml In Methanol
99. Ncgc00095158-02
100. Ncgc00095158-03
101. Ncgc00095158-04
102. Ncgc00095158-05
103. Ncgc00095158-08
104. Ac-12065
105. Sbi-0207037.p001
106. Secnidazole 100 Microg/ml In Acetonitrile
107. Db-000688
108. Ft-0601624
109. S2537
110. Sw197526-3
111. D07353
112. 1-(2- Hydroxypropyl)-2-methyl-5-nitroimidazole
113. 1h-imidazole-1-ethanol, A,2-dimethyl-5-nitro-
114. Ab00456738-13
115. Ab00456738-15
116. Ab00456738_16
117. Ab00456738_17
118. 366s958
119. A821901
120. J-019291
121. Q4413249
122. Sr-01000685111-4
123. Sr-01000685111-6
124. Sr-01000685111-7
125. .alpha.,2-dimethyl-5-nitroimidazole-1-ethanol
126. Brd-a70083328-001-02-9
127. Brd-a70083328-001-12-8
128. 1-(2-methyl-5-nitro-1h-imidazol-1-yl) Propan-2- Ol
129. 1-(2-methyl-5-nitro-imidazol-1-yl)propan-2-ol;secnidazole
Molecular Weight | 185.18 g/mol |
---|---|
Molecular Formula | C7H11N3O3 |
XLogP3 | 0.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 185.08004122 g/mol |
Monoisotopic Mass | 185.08004122 g/mol |
Topological Polar Surface Area | 83.9 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 194 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Secnidazole is indicated for the treatment of trichomoniasis in adults and bacterial vaginosis in adult women.
FDA Label
Secnidazole is a nitroimidazole antimicrobial drug that displays selectivity against many anaerobic Gram-positive and Gram-negative bacteria and protozoa. In vitro studies demonstrates the effectiveness of the drug against *Bacteroides fragilis*, *Trichomonas vaginalis*, *Entamoeba histolytica* and *Giardia lamblia*. There is no significant bacterial or protozoal resistance reported from secnidazole treatment.
Antiprotozoal Agents
Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)
P01AB07
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AB - Nitroimidazole derivatives
P01AB07 - Secnidazole
Absorption
Secnidazole is rapidly and completely absorbed after oral administration. Following a single oral dose of 2 g in healthy adult female subjects, the mean (SD) secnidazole peak plasma concentration (Cmax) of 45.4 (7.64) mcg/mL and mean (SD) systemic exposure (AUC0-inf) of 1331.6 (230.16) mcg x hr/mL was reached. Median (range) time to peak concentration (Tmax) was 4.0 (3.0-4.0) hours.
Route of Elimination
The predominant route of elimination is renal elimination. Following a single oral dose of 2g secnidazole, approximately 15% of the drug is excreted as unchanged compoung in the urine.
Volume of Distribution
The apparent volume of distribution of secnidazole is approximately 42-49 L.
Clearance
The total body clearance of secnidazole is approximately 25 mL/min. The renal clearance of secnidazole is approximately 3.9 mL/min.
According to *in vitro* studies, secnidazole is metabolized via oxidation by human hepatic CYP450 enzyme system with 1% conversion to metabolites.
The plasma elimination half-life for secnidazole is approximately 17 hours.
Secnidazole enters the bacterial cell as a prodrug without an antimicrobial activity. The drug is converted to an active form via reduction of nitro groups to radical anions by bacterial enzymes. The radical anions are thought to interfere with bacterial DNA synthesis of susceptible isolates.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Taste Masked Pellets S...
Dosage Strength : 2G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Taste Masked Pellets S...
Dosage Strength : 2G
Brand Name :
Approval Date :
Application Number :
Registration Country : France
Regulatory Info : Generic
Registration Country : India
Brand Name : SAMITOL
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging : PVC/PVDC Blister
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging : PVC/PVDC Blister
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 500MG
Brand Name : SAMITOL
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Coated IR Pellets
Dosage Strength : 50%/W/W
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Coated IR Pellets
Dosage Strength : 50%/W/W
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : France
Brand Name : Secnidal®
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage :
Dosage Strength :
Brand Name : Secnidal®
Approval Date :
Application Number :
Registration Country : France
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Packaging :
Regulatory Info : Generic ACTD Dossier- Available
Dosage : Tablet
Dosage Strength : 1000MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Brand Name : SECNIDOX
Dosage Form : FILM COATED TABLET
Dosage Strength : 500MG
Packaging : 2 OR 4 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 2 OR 4 TABLETS
Regulatory Info :
Dosage : FILM COATED TABLET
Dosage Strength : 500MG
Brand Name : SECNIDOX
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : SECNIDOX
Dosage Form : FILM COATED TABLET
Dosage Strength : 1000MG
Packaging : 2 OR 4 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 2 OR 4 TABLETS
Regulatory Info :
Dosage : FILM COATED TABLET
Dosage Strength : 1000MG
Brand Name : SECNIDOX
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Kenya
Brand Name : SEZOL DS
Dosage Form : Tablet
Dosage Strength : 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Kenya
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 1G
Brand Name : SEZOL DS
Approval Date :
Application Number :
Registration Country : Kenya
Regulatory Info : Generic
Registration Country : India
Fluconazole; Azithromycin; Secnidazole
Brand Name :
Dosage Form : TABLET
Dosage Strength : 150MG; 1000MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Fluconazole; Azithromycin; Secnidazole
Dosage : TABLET
Dosage Strength : 150MG; 1000MG; 1000MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?